Let’s Talk About Mental Health
A recent survey examined the relationships – or lack thereof – between pharma companies and mental health patient groups
Roisin McGuigan |
A recent report has ranked the pharma industry’s reputation among mental health-focused patient groups. And the findings show that the industry has a long way to go. Nearly half of the patient groups surveyed did not work with any pharma companies, and 11 percent only worked with one or two (1).
“We were quite surprised at the low level of networking between pharma and mental health patient groups,” says Alex Wyke, CEO of PatientView, the company behind the report. Of 101 participating patient groups, after quite high scores from the leading companies (Janssen, Lundbeck, and Eli Lilly), the numbers drop substantially. Of course, it’s important to remember that companies will not deal with every kind of mental health condition, and some may be extremely specialized and only deal in small areas of the field. But even so, the level of networking was still low when compared to other disease areas, such as cancer.”
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.